Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Revenio Group Oyj is a company focused on providing medical diagnostic solutions, primarily in the fields of ophthalmology. It is known for its innovative products, such as tonometers for eye pressure measurements, which are important in glaucoma examinations. Founded in Finland, the company has its headquarters in Vantaa. Revenio leverages its specialized expertise in medical technology to address specific healthcare needs, with a strategic focus on precision, reliability, and ease of use in its devices. The company's geographic footprint extends across multiple international markets, facilitated by a network of distributors and partners.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
Revenio Group OyjJohnson & Johnson
Last price
€10.59$263.81
Currency
EUR
USD
€445M$621B
21.5039.15
€0.49$6.58
0.880.21
0$5.28
02.08%
Sector
HealthHealth
Employees
765138,200
Ticker
€REG1V$JNJ
Primary listing
XHELNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €REG1V or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.